Possible Influence of Clinical Stage and Type of Treatment in the Persistence of Residual Circulating t(14;18)-Positive Cells in Follicular Lymphoma Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Possible Influence of Clinical Stage and Type of Treatment in the Persistence of Residual Circulating t(14;18)-Positive Cells in Follicular Lymphoma Patients

Published:2004-03 Issue:3 Volume:45 Page:539-545
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Colleoni Gisele WB,Duarte Luiz Cláudio C,Kerbauy Fábio R,Noguti Maria Aparecida E,Felix Roberta Spetic,De Oliveira José Salvador R,Figueiredo Maria Stella,Alves Antonio Correa

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/1042819031000159303

Reference21 articles.

1. The Non-Hodgkin Lymphoma Pathologic Classification Project

2. Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation

3. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head and neck follicular lymphoma with marginal zone differentiation and BCL2 translocation t(14;18) in both nodular and extranodular sites: a case report with mini-review;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-10

2. MOLECULAR EVALUATION OF t(14;18)(bcl-2/IgH) TRANSLOCATION IN FOLLICULAR LYMPHOMA AT DIAGNOSIS USING PARAFFIN-EMBEDDED TISSUE SECTIONS;Turkish Journal of Hematology;2012

3. Treatment strategies in limited stage follicular NHL;Best Practice & Research Clinical Haematology;2011-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP